Pasithea Therapeutics Corp. (KTTA)

Nasdaq · Pharmaceutical Preparations · Inc. DE

What they're doing

Between 2026-06-14 and 2026-09-12, public records show 1 signal for Pasithea Therapeutics Corp.. Most notable: 2026-06-17: Coastlands Capital LP (ten_percent_owner) bought $53k of stock. Federal contract obligations over the last 24 months total $0. This summary was assembled automatically from SEC EDGAR, USAspending.gov, U.S. Senate lobbying disclosures and Wikimedia pageview counts.

Generated 2026-09-12 from public records.

Signals, last 12 months

  1. Insider purchase
    Coastlands Capital LP (ten_percent_owner) bought $53k of stock
  2. Material 8-K filing
    Filed 8-K disclosing director or officer change
  3. Material 8-K filing
    Filed 8-K disclosing director or officer change
  4. Material 8-K filing
    Filed 8-K disclosing material agreement
  5. Insider purchase
    STEINMAN LAWRENCE (director) bought $100k of stock
  6. Material 8-K filing
    Filed 8-K disclosing director or officer change

Insider transactions

DateInsiderRoleCodeSharesPriceValue
2026-06-17Coastlands Capital LPten percent ownerP100,0000.53$53,000
2025-11-28STEINMAN LAWRENCEdirectorP133,3330.75$100,000
2025-11-28Schneiderman Daniel HofficerA26,6670.75$20,000
2025-11-28Marques TiagodirectorP33,3330.75$25,000
2025-11-28Dumesnil SimondirectorP33,3330.75$25,000
2025-11-28Leahy EmerdirectorA33,3330.75$25,000
2025-05-12Marques TiagodirectorS9600.83$797

Federal contracts

No federal contract actions on record for this recipient mapping.

Lobbying

No federal lobbying filings on record for this client mapping.

Public attention

No Wikipedia pageview data linked to this company.

Recent filings